Volume 9, Number 10—October 2003
Wild-type Measles Virus in Brain Tissue of Children with Subacute Sclerosing Panencephalitis, Argentina
|Date of birth||Jan-98||Feb-98||Jul-98||Mar-98||Nov-97||Nov-97||Sep-96||Nov-97|
|Date of measles disease||Sep-98||Sep-98||May-99||Sep-98||Sep-98||N/A||Jul-97||Jul-98|
|Date of SSPE onset||May-01||Dec-01||Feb-02||Jun-02||Aug-02||Sep-02||Jan-03||Feb-03|
|CSF antibody titers||1:1600||1:1600||1:3200||1:3200||1:400||1:400||1:1600||1:400|
|Serum antibody titers||>1:3200||>1:3200||1:12800||>1:3200||>1:3200||1:12800||N/A||1:400|
|Initial diagnosis||Progressive myoclonic epilepsy||Acute disseminated encephalo-myelitis||Progressive myoclonic epilepsy||Neuronal ceroid lipofucsinosis||Lennox Gastaut syndrome||Progressive myoclonic atonic epilepsy||Chorioretinitis||Ataxia|
aMolecular studies were done for SSPE patients highlighted in bold type. N/A, not available; GBA, greater Buenos Aires metropolitan area; NW, northwestern region from Argentina; NE, northeastern region from Argentina; CSF, cerebrospinal fluid.
Page created: January 10, 2011
Page updated: January 10, 2011
Page reviewed: January 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.